ARCHIVES

ODAC Recommends TICE BCG Approval For Recurrent Bladder Cancer Prevention

This article is from The Cancer Letter archive.

Vol. 23 No. 01 | January 10, 1997

Download PDF Visit The Full Archive

Related Articles

ASCO Publishes Two Clinical Guidelines For Treating HER2-Positive Breast Cancer

May 30, 2014

Review Group Urges Increased Funding For NCI AIDS Drug Discovery Program

December 3, 1999

Letter to the Editor: A Victory for Research, But Real Work Is Ahead

November 26, 1999

In Brief: On “Clouds Of glory,” And An Italian Bike, Varmus Takes Office As 14th NIH Director

November 26, 1993

Avon Awards $50 Million To NCI And Three Centers.

October 12, 2001

American Health Fdn. Honors NCI On Act’s 20th Anniversary

December 13, 1991